BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 25343957)

  • 1. Recurrent ETNK1 mutations in atypical chronic myeloid leukemia.
    Gambacorti-Passerini CB; Donadoni C; Parmiani A; Pirola A; Redaelli S; Signore G; Piazza V; Malcovati L; Fontana D; Spinelli R; Magistroni V; Gaipa G; Peronaci M; Morotti A; Panuzzo C; Saglio G; Usala E; Kim DW; Rea D; Zervakis K; Viniou N; Symeonidis A; Becker H; Boultwood J; Campiotti L; Carrabba M; Elli E; Bignell GR; Papaemmanuil E; Campbell PJ; Cazzola M; Piazza R
    Blood; 2015 Jan; 125(3):499-503. PubMed ID: 25343957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of ETNK1 in aCML and CMML.
    Kosmider O
    Blood; 2015 Jan; 125(3):422-3. PubMed ID: 25593331
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia.
    Lasho TL; Finke CM; Zblewski D; Patnaik M; Ketterling RP; Chen D; Hanson CA; Tefferi A; Pardanani A
    Blood Cancer J; 2015 Jan; 5(1):e275. PubMed ID: 25615281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia.
    Fontana D; Ramazzotti D; Aroldi A; Redaelli S; Magistroni V; Pirola A; Niro A; Massimino L; Mastini C; Brambilla V; Bombelli S; Bungaro S; Morotti A; Rea D; Stagno F; Martino B; Campiotti L; Caocci G; Usala E; Merli M; Onida F; Bregni M; Elli EM; Fumagalli M; Ciceri F; Perego RA; Pagni F; Mologni L; Piazza R; Gambacorti-Passerini C
    Hemasphere; 2020 Dec; 4(6):e497. PubMed ID: 33196013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ETNK1 mutation occurs in a wide spectrum of myeloid neoplasms and is not specific for atypical chronic myeloid leukemia.
    Shuai W; Zuo Z; Li N; Garces S; Jelloul FZ; Ok CY; Li S; Xu J; You MJ; Wang W; Rehder C; Jabbour EJ; Patel KP; Medeiros LJ; Yin CC
    Cancer; 2023 Mar; 129(6):878-889. PubMed ID: 36583229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia.
    Faisal M; Stark H; Büsche G; Schlue J; Teiken K; Kreipe HH; Lehmann U; Bartels S
    Cancer Med; 2019 Feb; 8(2):742-750. PubMed ID: 30635983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETNK1 mutations induce a mutator phenotype that can be reverted with phosphoethanolamine.
    Fontana D; Mauri M; Renso R; Docci M; Crespiatico I; Røst LM; Jang M; Niro A; D'Aliberti D; Massimino L; Bertagna M; Zambrotta G; Bossi M; Citterio S; Crescenzi B; Fanelli F; Cassina V; Corti R; Salerno D; Nardo L; Chinello C; Mantegazza F; Mecucci C; Magni F; Cavaletti G; Bruheim P; Rea D; Larsen S; Gambacorti-Passerini C; Piazza R
    Nat Commun; 2020 Nov; 11(1):5938. PubMed ID: 33230096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia.
    Patnaik MM; Barraco D; Lasho TL; Finke CM; Reichard K; Hoversten KP; Ketterling RP; Gangat N; Tefferi A
    Am J Hematol; 2017 Jun; 92(6):542-548. PubMed ID: 28314085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical chronic myeloid leukemia: a rare entity with management challenges.
    Dhakal P; Gundabolu K; Amador C; Rayamajhi S; Bhatt VR
    Future Oncol; 2018 Jan; 14(2):177-185. PubMed ID: 29226717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatic SETBP1 mutations in myeloid neoplasms.
    Makishima H
    Int J Hematol; 2017 Jun; 105(6):732-742. PubMed ID: 28447248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic SETBP1 mutations in myeloid malignancies.
    Makishima H; Yoshida K; Nguyen N; Przychodzen B; Sanada M; Okuno Y; Ng KP; Gudmundsson KO; Vishwakarma BA; Jerez A; Gomez-Segui I; Takahashi M; Shiraishi Y; Nagata Y; Guinta K; Mori H; Sekeres MA; Chiba K; Tanaka H; Muramatsu H; Sakaguchi H; Paquette RL; McDevitt MA; Kojima S; Saunthararajah Y; Miyano S; Shih LY; Du Y; Ogawa S; Maciejewski JP
    Nat Genet; 2013 Aug; 45(8):942-6. PubMed ID: 23832012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia.
    Piazza R; Valletta S; Winkelmann N; Redaelli S; Spinelli R; Pirola A; Antolini L; Mologni L; Donadoni C; Papaemmanuil E; Schnittger S; Kim DW; Boultwood J; Rossi F; Gaipa G; De Martini GP; di Celle PF; Jang HG; Fantin V; Bignell GR; Magistroni V; Haferlach T; Pogliani EM; Campbell PJ; Chase AJ; Tapper WJ; Cross NC; Gambacorti-Passerini C
    Nat Genet; 2013 Jan; 45(1):18-24. PubMed ID: 23222956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathogenesis of
    Fontana D; Gambacorti-Passerini C; Piazza R
    Front Oncol; 2021; 11():756348. PubMed ID: 34858828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic myelomonocytic leukemia and atypical chronic myeloid leukemia: novel pathogenetic lesions.
    Muramatsu H; Makishima H; Maciejewski JP
    Semin Oncol; 2012 Feb; 39(1):67-73. PubMed ID: 22289493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical Chronic Myeloid Leukemia: Where Are We Now?
    Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Iaquinta G; Scalzulli E; Angeloni S; Carmosino I; Costa A; Ielo C; Passucci M; Masucci C; Martelli M; Grammatico P; Breccia M
    Leuk Lymphoma; 2023 Oct; 64(10):1730-1732. PubMed ID: 37435984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical CML: diagnosis and treatment.
    Breccia M
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):476-482. PubMed ID: 38066919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular characterization of atypical chronic myeloid leukemia and chronic neutrophilic leukemia].
    Senín A; Arenillas L; Martínez-Avilés L; Fernández-Rodríguez C; Bellosillo B; Florensa L; Besses C; Álvarez-Larrán A
    Med Clin (Barc); 2015 Jun; 144(11):487-90. PubMed ID: 24854193
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Linder K; Iragavarapu C; Liu D
    Biomark Res; 2017; 5():33. PubMed ID: 29225884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia.
    Meggendorfer M; Haferlach T; Alpermann T; Jeromin S; Haferlach C; Kern W; Schnittger S
    Haematologica; 2014 Dec; 99(12):e244-6. PubMed ID: 25239264
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.